Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 3/2011

01-05-2011 | Original Article

Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children

Authors: Jerzy Konstantynowicz, Dariusz M. Lebensztejn, Elzbieta Skiba, Maria E. Sobaniec-Lotowska, Pawel Abramowicz, Janina Piotrowska-Jastrzebska, Maciej Kaczmarski

Published in: Journal of Bone and Mineral Metabolism | Issue 3/2011

Login to get access

Abstract

Chronic liver disease in adults is a risk factor of osteoporosis, but little is known about risk of fractures in children with non-cholestatic liver disease. The aim of this study was to investigate associations among the severity of liver fibrosis, bone mass and low-energy fractures in children. History of fractures, anthropometry, and bone mass and size were examined in 39 Caucasian children (25 boys, 14 girls) aged 7.1–18 years (mean 11.9 ± 3.1) with chronic hepatitis B and liver fibrosis evidenced by liver biopsy. Severity of liver fibrosis was based on histological classification according to the method of Batts and Ludwig (mild, 1–2 scores; advanced, 3 scores) and Ishak (1–3 and 4–5 scores, respectively). Bone mineral content (BMC), density (BMD) and body composition were determined in the total body and lumbar spine using dual energy X-ray absorptiometry. Seven subjects (4 girls, 3 boys; 18% of the sample) had low BMD in the total body and lumbar spine region (Z-scores below −2.0). No associations were found among BMC, BMD, bone size and the severity of liver fibrosis. Nine boys (36% of all boys) and one girl reported repeated fractures (forearm, wrist, tibia, ankle, humerus), showing trends similar to the prevalence in general population. Fractures were neither associated with lower BMD/BMC nor with scores of liver fibrosis. Deficits in BMD in children with chronic hepatitis B are not associated with the severity of liver fibrosis. This study suggests that non-cholestatic liver disease does not increase the risk of low-energy fractures during growth. From the practical perspective, however, children with chronic liver disease should be screened for history and clinical risk factors for fractures rather than referred to bone density testing.
Literature
1.
go back to reference Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D (1998) Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28:695–699PubMedCrossRef Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D (1998) Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28:695–699PubMedCrossRef
2.
go back to reference Masaki K, Shiomi S, Kuroki T, Tanaka T, Monna T, Ochi H (1998) Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver. J Gastroenterol 33:236–240PubMedCrossRef Masaki K, Shiomi S, Kuroki T, Tanaka T, Monna T, Ochi H (1998) Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver. J Gastroenterol 33:236–240PubMedCrossRef
3.
go back to reference Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH (2004) Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 10:648–653PubMedCrossRef Sokhi RP, Anantharaju A, Kondaveeti R, Creech SD, Islam KK, Van Thiel DH (2004) Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl 10:648–653PubMedCrossRef
4.
go back to reference Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG (2004) Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 89:4325–4330PubMedCrossRef Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG (2004) Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 89:4325–4330PubMedCrossRef
5.
go back to reference Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, Millikan WJ, Galloway JR (1990) Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 12:273–280PubMedCrossRef Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, Millikan WJ, Galloway JR (1990) Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 12:273–280PubMedCrossRef
6.
go back to reference Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, Peltekova VD, Heathcote EJ (2000) Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 118:145–151PubMedCrossRef Springer JE, Cole DE, Rubin LA, Cauch-Dudek K, Harewood L, Evrovski J, Peltekova VD, Heathcote EJ (2000) Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 118:145–151PubMedCrossRef
7.
go back to reference Bagur A, Mautalen C, Findor J, Sorda J, Somoza J (1998) Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385–390PubMedCrossRef Bagur A, Mautalen C, Findor J, Sorda J, Somoza J (1998) Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385–390PubMedCrossRef
8.
go back to reference Newton J, Francis R, Prince M, James O, Bassendine M, Rawlings D, Jones D (2001) Osteoporosis in primary biliary cirrhosis revisited. Gut 49:282–287PubMedCrossRef Newton J, Francis R, Prince M, James O, Bassendine M, Rawlings D, Jones D (2001) Osteoporosis in primary biliary cirrhosis revisited. Gut 49:282–287PubMedCrossRef
9.
go back to reference Hirano Y, Kishimoto H, Hagino H, Teshima R (1999) The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence. J Bone Miner Metab 17:119–124PubMedCrossRef Hirano Y, Kishimoto H, Hagino H, Teshima R (1999) The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence. J Bone Miner Metab 17:119–124PubMedCrossRef
10.
go back to reference Olsson R, Johansson C, Lindstedt G, Mellstrom D (1994) Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 29:753–756PubMedCrossRef Olsson R, Johansson C, Lindstedt G, Mellstrom D (1994) Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 29:753–756PubMedCrossRef
11.
go back to reference Isaia G, Di Stefano M, Roggia C, Ardissone P, Rosina F (1998) Bone disorders in cholestatic liver diseases. Forum (Genova) 8:28–38 Isaia G, Di Stefano M, Roggia C, Ardissone P, Rosina F (1998) Bone disorders in cholestatic liver diseases. Forum (Genova) 8:28–38
12.
go back to reference Sylvester FA (1999) Bone abnormalities in gastrointestinal and hepatic disease. Curr Opin Pediatr 11:402–407PubMedCrossRef Sylvester FA (1999) Bone abnormalities in gastrointestinal and hepatic disease. Curr Opin Pediatr 11:402–407PubMedCrossRef
13.
go back to reference Baroncelli GI, Federico G, Bertelloni S, Sodini F, De Terlizzi F, Cadossi R, Saggese G (2003) Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. Pediatr Res 54:125–136PubMedCrossRef Baroncelli GI, Federico G, Bertelloni S, Sodini F, De Terlizzi F, Cadossi R, Saggese G (2003) Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. Pediatr Res 54:125–136PubMedCrossRef
14.
go back to reference Tanner JM (1978) Physical growth and development. In: Forfar J, Arnell CC (eds) Textbook of pediatrics, 2nd edn. Edinbourgh, Scotland, pp 249–303 Tanner JM (1978) Physical growth and development. In: Forfar J, Arnell CC (eds) Textbook of pediatrics, 2nd edn. Edinbourgh, Scotland, pp 249–303
15.
go back to reference Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19:1409–1417PubMedCrossRef Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19:1409–1417PubMedCrossRef
16.
go back to reference Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699PubMedCrossRef Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699PubMedCrossRef
17.
go back to reference Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the international society for clinical densitometry and executive summary of the 2007 ISCD pediatric position development conference. J Clin Densitom 11:6–21PubMedCrossRef Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the international society for clinical densitometry and executive summary of the 2007 ISCD pediatric position development conference. J Clin Densitom 11:6–21PubMedCrossRef
18.
go back to reference Pares A, Guanabens N, Alvarez L, De Osaba MJ, Oriola J, Pons F, Caballeria L, Monegal A, Salvador G, Jo J, Peris P, Rivera F, Ballesta AM, Rodes J (2001) Collagen type I alpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 33:554–560PubMedCrossRef Pares A, Guanabens N, Alvarez L, De Osaba MJ, Oriola J, Pons F, Caballeria L, Monegal A, Salvador G, Jo J, Peris P, Rivera F, Ballesta AM, Rodes J (2001) Collagen type I alpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 33:554–560PubMedCrossRef
19.
go back to reference Duarte MP, Farias ML, Coelho HS, Mendonca LM, Stabnov LM, d Oliveira M, Lamy RA, Oliveira DS (2001) Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 16:1022–1027PubMedCrossRef Duarte MP, Farias ML, Coelho HS, Mendonca LM, Stabnov LM, d Oliveira M, Lamy RA, Oliveira DS (2001) Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 16:1022–1027PubMedCrossRef
20.
go back to reference Crawford BA, Kam C, Donaghy AJ, McCaughan GW (2003) The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 14:987–994PubMedCrossRef Crawford BA, Kam C, Donaghy AJ, McCaughan GW (2003) The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 14:987–994PubMedCrossRef
21.
go back to reference Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, Minguzzi L, Gasbarrini G, Bernardi M (2000) Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci 45:1392–1399PubMedCrossRef Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, Minguzzi L, Gasbarrini G, Bernardi M (2000) Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci 45:1392–1399PubMedCrossRef
22.
go back to reference Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11:1843–1847PubMed Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11:1843–1847PubMed
23.
go back to reference Gur A, Dikici B, Nas K, Bosnak M, Haspolat K, Sarac AJ (2005) Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent osteoporosis? BMC Gastroenterol 5:30PubMedCrossRef Gur A, Dikici B, Nas K, Bosnak M, Haspolat K, Sarac AJ (2005) Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent osteoporosis? BMC Gastroenterol 5:30PubMedCrossRef
24.
go back to reference Ma DQ, Jones G (2002) Clinical risk factors but not bone density are associated with prevalent fractures in prepubertal children. J Paediatr Child Health 38:497–500PubMedCrossRef Ma DQ, Jones G (2002) Clinical risk factors but not bone density are associated with prevalent fractures in prepubertal children. J Paediatr Child Health 38:497–500PubMedCrossRef
26.
go back to reference Khosla S, Melton LJ 3rd, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL (2003) Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA 290:1479–1485PubMedCrossRef Khosla S, Melton LJ 3rd, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL (2003) Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA 290:1479–1485PubMedCrossRef
27.
go back to reference Lyons RA, Delahunty AM, Kraus D, Heaven M, McCabe M, Allen H, Nash P (1999) Children’s fractures: a population based study. Inj Prev 5:129–132PubMedCrossRef Lyons RA, Delahunty AM, Kraus D, Heaven M, McCabe M, Allen H, Nash P (1999) Children’s fractures: a population based study. Inj Prev 5:129–132PubMedCrossRef
28.
go back to reference Jones IE, Cannan R, Goulding A (2000) Distal forearm fractures in New Zealand children: annual rates in a geographically defined area. N Z Med J 113:443–445PubMed Jones IE, Cannan R, Goulding A (2000) Distal forearm fractures in New Zealand children: annual rates in a geographically defined area. N Z Med J 113:443–445PubMed
29.
go back to reference Hagino H, Yamamoto K, Ohshiro H, Nose T (2000) Increasing incidence of distal radius fractures in Japanese children and adolescents. J Orthop Sci 5:356–360PubMedCrossRef Hagino H, Yamamoto K, Ohshiro H, Nose T (2000) Increasing incidence of distal radius fractures in Japanese children and adolescents. J Orthop Sci 5:356–360PubMedCrossRef
30.
go back to reference Jones IE, Williams SM, Dow N, Goulding A (2002) How many children remain fracture-free during growth? A longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development study. Osteoporos Int 13:990–995PubMedCrossRef Jones IE, Williams SM, Dow N, Goulding A (2002) How many children remain fracture-free during growth? A longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development study. Osteoporos Int 13:990–995PubMedCrossRef
31.
go back to reference Brudvik C, Hove LM (2003) Childhood fractures in Bergen, Norway: identifying high-risk groups and activities. J Pediatr Orthop 23:629–634PubMedCrossRef Brudvik C, Hove LM (2003) Childhood fractures in Bergen, Norway: identifying high-risk groups and activities. J Pediatr Orthop 23:629–634PubMedCrossRef
32.
go back to reference Konstantynowicz J, Bialokoz-Kalinowska I, Motkowski R, Abramowicz P, Piotrowska-Jastrzebska J, Sienkiewicz J, Seeman E (2005) The characteristics of fractures in Polish adolescents aged 16–20 years. Osteoporos Int 16:1397–1403PubMedCrossRef Konstantynowicz J, Bialokoz-Kalinowska I, Motkowski R, Abramowicz P, Piotrowska-Jastrzebska J, Sienkiewicz J, Seeman E (2005) The characteristics of fractures in Polish adolescents aged 16–20 years. Osteoporos Int 16:1397–1403PubMedCrossRef
33.
go back to reference Goulding A, Jones IE, Taylor RW, Williams SM, Manning PJ (2001) Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy X-ray absorptiometry study. J Pediatr 139:509–515PubMedCrossRef Goulding A, Jones IE, Taylor RW, Williams SM, Manning PJ (2001) Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy X-ray absorptiometry study. J Pediatr 139:509–515PubMedCrossRef
34.
go back to reference Ma D, Jones G (2004) Soft drink and milk consumption, physical activity, bone mass, and upper limb fractures in children: a population-based case-control study. Calcif Tissue Int 75:286–291PubMedCrossRef Ma D, Jones G (2004) Soft drink and milk consumption, physical activity, bone mass, and upper limb fractures in children: a population-based case-control study. Calcif Tissue Int 75:286–291PubMedCrossRef
35.
go back to reference Ma D, Morley R, Jones G (2004) Risk-taking, coordination and upper limb fractures in children: a population based case–control study. Osteoporos Int 15:633–638PubMedCrossRef Ma D, Morley R, Jones G (2004) Risk-taking, coordination and upper limb fractures in children: a population based case–control study. Osteoporos Int 15:633–638PubMedCrossRef
36.
go back to reference Tsuneoka K, Tameda Y, Takase K, Nakano T (1996) Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 31:669–678PubMedCrossRef Tsuneoka K, Tameda Y, Takase K, Nakano T (1996) Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 31:669–678PubMedCrossRef
37.
go back to reference George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N (2009) Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol 28:3516–3522CrossRef George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N (2009) Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol 28:3516–3522CrossRef
Metadata
Title
Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children
Authors
Jerzy Konstantynowicz
Dariusz M. Lebensztejn
Elzbieta Skiba
Maria E. Sobaniec-Lotowska
Pawel Abramowicz
Janina Piotrowska-Jastrzebska
Maciej Kaczmarski
Publication date
01-05-2011
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 3/2011
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-010-0219-7

Other articles of this Issue 3/2011

Journal of Bone and Mineral Metabolism 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.